Highlights in GEP-NETs From the 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease: Commentary

摘要

The 13th Annual European Neuroendocrine Tumor Society (ENETS) conference was held in Barcelona from March 9 through 11, 2016. Data were presented on several studies evaluating treatments for gastro-enteropancreatic neuroendocrine tumors (GEP-NETs), such as lanreotide depot/ autogel, octreotide, sunitinib, and radio-isotope therapy. In this commentary, we discuss selected abstracts from the meeting that will potentially impact the approach to managing GEP-NETs, as well as abstracts that present promising results from ongoing areas of research.